Comparative evaluation of pancreatic histopathology of rats treated with olanzapine, risperidone and streptozocin
AUTOR(ES)
Shah, Rehmat, Subhan, Fazal, Sultan, Sayed Mohammad, Ali, Gowhar, Ullah, Ihsan, Ullah, Sami
FONTE
Braz. J. Pharm. Sci.
DATA DE PUBLICAÇÃO
29/11/2018
RESUMO
Olanzapine and risperidone are widely prescribed atypical antipsychotics used in the treatment of schizophrenia and various other psychiatric disorders. Both of these drugs have been extensively reported to cause Type 2 diabetes mellitus and pancreatitis, however, the mechanism of olanzapine and risperidone-induced toxicity has not been so far unveiled. We, therefore, compared the streptozocin-induced pancreatic damage with that of pancreas isolated from olanzapine and risperidone treated rats. It was noticed that fibrotic growth, necrosis and derangement of the pancreatic islet cells caused by streptozocin were more pronounced than olanzapine and risperidone.
Documentos Relacionados
- Subjective response to antipsychotic treatment and compliance in schizophrenia. A naturalistic study comparing olanzapine, risperidone and haloperidol (EFESO Study)
- The Comparative Peripheral Anticholinergic-Like Adverse Event Profiles of Olanzapine and Risperidone
- Comparison of Risperidone and Olanzapine in Bipolar and Schizoaffective Disorders
- Diarrhea in streptozocin-treated rats. Loss of adrenergic regulation of intestinal fluid and electrolyte transport.
- Short-term oral administration of risperidone induces pancreatic damage and hyperamylasemia in Sprague-dawley rats